These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15323955)

  • 21. Ligand binding modulates the mechanical stability of dihydrofolate reductase.
    Ainavarapu SR; Li L; Badilla CL; Fernandez JM
    Biophys J; 2005 Nov; 89(5):3337-44. PubMed ID: 16100277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NMR solution structure of the antitumor compound PT523 and NADPH in the ternary complex with human dihydrofolate reductase.
    Johnson JM; Meiering EM; Wright JE; Pardo J; Rosowsky A; Wagner G
    Biochemistry; 1997 Apr; 36(15):4399-411. PubMed ID: 9109647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding the role of Leu22 variants in methotrexate resistance: comparison of wild-type and Leu22Arg variant mouse and human dihydrofolate reductase ternary crystal complexes with methotrexate and NADPH.
    Cody V; Luft JR; Pangborn W
    Acta Crystallogr D Biol Crystallogr; 2005 Feb; 61(Pt 2):147-55. PubMed ID: 15681865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Native Escherichia coli and murine dihydrofolate reductases contain late-folding non-native structures.
    Clark AC; Frieden C
    J Mol Biol; 1999 Jan; 285(4):1765-76. PubMed ID: 9917410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tight binding ligand approach to oligosaccharide-grafted protein.
    Totani K; Matsuo I; Ito Y
    Bioorg Med Chem Lett; 2004 May; 14(9):2285-9. PubMed ID: 15081026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure determination at 2.3 A of recombinant human dihydrofolate reductase ternary complex with NADPH and methotrexate-gamma-tetrazole.
    Cody V; Luft JR; Ciszak E; Kalman TI; Freisheim JH
    Anticancer Drug Des; 1992 Dec; 7(6):483-91. PubMed ID: 1285840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fundamental and biotechnological applications of neutron scattering measurements for macromolecular dynamics.
    Tehei M; Daniel R; Zaccai G
    Eur Biophys J; 2006 Sep; 35(7):551-8. PubMed ID: 16868745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cofactor binding and loop conformation on side chain methyl dynamics in dihydrofolate reductase.
    Schnell JR; Dyson HJ; Wright PE
    Biochemistry; 2004 Jan; 43(2):374-83. PubMed ID: 14717591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ligand-induced conformational changes in the crystal structures of Pneumocystis carinii dihydrofolate reductase complexes with folate and NADP+.
    Cody V; Galitsky N; Rak D; Luft JR; Pangborn W; Queener SF
    Biochemistry; 1999 Apr; 38(14):4303-12. PubMed ID: 10194348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consideration of the pH-dependent inhibition of dihydrofolate reductase by methotrexate.
    Cannon WR; Garrison BJ; Benkovic SJ
    J Mol Biol; 1997 Aug; 271(4):656-68. PubMed ID: 9281432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
    Senkovich O; Schormann N; Chattopadhyay D
    Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of ligand binding on the intraminimum dynamics of proteins.
    Alakent B; Baskan S; Doruker P
    J Comput Chem; 2011 Feb; 32(3):483-96. PubMed ID: 20730777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for a functional role of the dynamics of glycine-121 of Escherichia coli dihydrofolate reductase obtained from kinetic analysis of a site-directed mutant.
    Cameron CE; Benkovic SJ
    Biochemistry; 1997 Dec; 36(50):15792-800. PubMed ID: 9398309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclophilin-promoted folding of mouse dihydrofolate reductase does not include the slow conversion of the late-folding intermediate to the active enzyme.
    von Ahsen O; Lim JH; Caspers P; Martin F; Schönfeld HJ; Rassow J; Pfanner N
    J Mol Biol; 2000 Mar; 297(3):809-18. PubMed ID: 10731431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacophore-based molecular docking to account for ligand flexibility.
    Joseph-McCarthy D; Thomas BE; Belmarsh M; Moustakas D; Alvarez JC
    Proteins; 2003 May; 51(2):172-88. PubMed ID: 12660987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In search of dihydrofolate reductase.
    Huennekens FM
    Protein Sci; 1996 Jun; 5(6):1201-8. PubMed ID: 8762155
    [No Abstract]   [Full Text] [Related]  

  • 37. Preliminary joint X-ray and neutron protein crystallographic studies of ecDHFR complexed with folate and NADP+.
    Wan Q; Kovalevsky AY; Wilson MA; Bennett BC; Langan P; Dealwis C
    Acta Crystallogr F Struct Biol Commun; 2014 Jun; 70(Pt 6):814-8. PubMed ID: 24915100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate conjugates: a molecular in vivo protein tag.
    Miller LW; Sable J; Goelet P; Sheetz MP; Cornish VW
    Angew Chem Int Ed Engl; 2004 Mar; 43(13):1672-5. PubMed ID: 15038033
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of ionic interactions in ligand binding and catalysis of R67 dihydrofolate reductase.
    Hicks SN; Smiley RD; Hamilton JB; Howell EE
    Biochemistry; 2003 Sep; 42(36):10569-78. PubMed ID: 12962480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding techniques to study the allosteric energy cycle.
    Kranz JK; Clemente JC
    Methods Mol Biol; 2012; 796():3-17. PubMed ID: 22052482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.